Table 6.

Risk of MACE in Univariable and Multivariable Fine-Gray Hazard Model With Noncardiovascular Death as a Competing Event

	Univariable		Multivariable∗
	Hazard Ratio (95% CI)	p Value	Hazard Ratio (95% CI)	p Value
Age at start	0.98 (0.95–1.02)	0.44
Female	0.92 (0.45–1.89)	0.82
ICI	1.18 (0.57–2.43)	0.66	0.63 (0.29–1.35)	0.23
Nivolumab	1.16 (0.54–2.51)	0.70
Pembrolizumab	1.14 (0.47–2.75)	0.77
Atezolizumab	0.71 (0.17–3.03)	0.64
Elevated troponin I (>0.01 ng/ml)	9.82 (4.91–19.66)	<0.001	7.27 (2.72–19.43)	<0.001
Initial troponin (in ng/ml)	1.01 (0.99–1.02)	0.54
Peak troponin (in ng/ml)	1.01 (0.99–1.02)	0.20
Elevated BNP (>100 pg/ml)	5.14 (2.36–11.20)	<0.001	2.65 (1.01–6.92)	0.047

CI = confidence interval; other abbreviations as in Table 2.

^∗Adjusted for ICI, elevated serum troponin I, and elevated serum BNP categorical variables.